| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2011 | US7947686 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 05/24/2011 | US7947685 Pyrazine-2-carboxyamide derivatives |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors |
| 05/24/2011 | US7947682 Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents |
| 05/24/2011 | US7947681 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 05/24/2011 | US7947680 Adamantyl diamide derivatives and uses of same |
| 05/24/2011 | US7947679 Fungicides |
| 05/24/2011 | US7947678 Heterocyclic benzodiazepine CGRP receptor antagonists |
| 05/24/2011 | US7947677 Spirolactam tricyclic CGRP receptor antagonists |
| 05/24/2011 | US7947676 Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents |
| 05/24/2011 | US7947675 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 05/24/2011 | US7947674 Meso-substituted porphyrins |
| 05/24/2011 | US7947673 Removal excess iron from blood; using a compound such as 4-(3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl)benzoic acid |
| 05/24/2011 | US7947672 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 05/24/2011 | US7947671 Synthesis of naturally occuring ecteinascidins and related compounds |
| 05/24/2011 | US7947670 Benzoquinone ansamycin; administered orally; dose of 15 mg/kg; achieve an area under the curve of at least 100 ng*hr/ml; cancer, neoplastic disease state, hyperproliferative disorder; mixtures of geldanamycin analogs and crystallization inhibitors dramatically improve bioavailability |
| 05/24/2011 | US7947669 Agent for improving insulin resistance |
| 05/24/2011 | US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 05/24/2011 | US7947667 Aromatization; hydrolysis; deblocking, deprotecting; oxidation; for production of fulvestrant |
| 05/24/2011 | US7947666 2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs |
| 05/24/2011 | US7947665 LPA receptor agonists and antagonists and methods of use |
| 05/24/2011 | US7947663 Inhibitors of fatty acid amide hydrolase |
| 05/24/2011 | US7947662 Folates, compositions and uses thereof |
| 05/24/2011 | US7947661 Compounds for the treatment of marihuana dependence, withdrawal, and usage |
| 05/24/2011 | US7947659 iRNA agents targeting VEGF |
| 05/24/2011 | US7947657 Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA) |
| 05/24/2011 | US7947656 Processes for producing cellooligosaccharide |
| 05/24/2011 | US7947463 Diagnosing cancer; measure antibody inhibitor, compare to control, reduced amounts of inhibitor indicates receptivity to cancer |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947449 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/24/2011 | US7947313 Compositions for diabetes treatment and prophylaxis |
| 05/24/2011 | US7947312 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 05/24/2011 | US7947311 Insect repellent concentrate formulation |
| 05/24/2011 | US7947310 Method of treating stroke or brain injury patients based on the intravenous administration of magnesium cations and concurrent administration of an oxygen gas mixture |
| 05/24/2011 | US7947309 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 05/24/2011 | US7947308 Effervescent powders for inhalation |
| 05/24/2011 | US7947303 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/24/2011 | US7947301 Medical inserts; low concentration of antiinfection agent; efficiency; covering exterior surface with minocycline and rifampicin |
| 05/24/2011 | US7947299 Compositions and techniques for localized therapy |
| 05/24/2011 | US7947298 Animal repellent composition and method |
| 05/24/2011 | US7947297 Plastic film; microbiocides; discoloration inhibition; heat resistance at high temperature |
| 05/24/2011 | US7947296 Such as 2,4,4'-trichloro-2'-hydroxydiphenyl ether (triclosan) and zinc oxide; dicoloration inhibition; weatherproofing; radiation resistance |
| 05/24/2011 | US7947295 Ophthalmic compositions containing a synergistic combination of two polymers |
| 05/24/2011 | US7947291 Modified surface antigen |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | US7947278 administer effective dose of human Egfl7 polypeptide agonist; intravenous, intra-arterial, intra-pericardial, systemic, subcutaneous, intramuscular, by inhalation, topical, transdermal; tumor growth, atherosclerosis, diabetic retinopathy, age-related maculopathy, and retrolental fibroplasia |
| 05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 05/24/2011 | US7947262 Administering fullerenes to which are attached IgE Fc or stem cell factor (SCF) peptides |
| 05/24/2011 | US7947261 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs |
| 05/24/2011 | US7947257 Method of intranasal administration of granisetron |
| 05/24/2011 | CA2645967C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/24/2011 | CA2633170C Butylphthalide intravenous emulsion and application thereof |
| 05/24/2011 | CA2629466C Beta-secretase modulators and methods of use |
| 05/24/2011 | CA2628729C Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 05/24/2011 | CA2624589C Neramexane modified release matrix tablet |
| 05/24/2011 | CA2623964C Using metal aquacomplexes for preparation pure amino acid chelates for human and veterinary use |
| 05/24/2011 | CA2585253C Antimicrobial 2-deoxystreptamine compounds |
| 05/24/2011 | CA2574491C Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones |
| 05/24/2011 | CA2568445C Immediate release formulations of memantine oral dosage forms |
| 05/24/2011 | CA2544648C Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| 05/24/2011 | CA2537066C Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/24/2011 | CA2533196C Use of pinolenic acid and derivatives thereof for weight management |
| 05/24/2011 | CA2510167C Derivatives of asimadoline with covalently bonded acids |
| 05/24/2011 | CA2509023C Multilayer dosage forms containing nsaids and triptans |
| 05/24/2011 | CA2508194C Use of ibudilast as a phosphodiesterase 10a inhibitor |
| 05/24/2011 | CA2506159C Fat regulation |
| 05/24/2011 | CA2504663C Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/24/2011 | CA2501395C Prolonged release pharmaceutical composition |
| 05/24/2011 | CA2499690C Diaryl ethers as opioid receptor antagonist |
| 05/24/2011 | CA2499195C A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 05/24/2011 | CA2497569C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound |
| 05/24/2011 | CA2493764C Improved treatment of cancer with glutamine |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2491701C Fredericamycin derivatives as drugs for tumor treatment |
| 05/24/2011 | CA2491313C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
| 05/24/2011 | CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 05/24/2011 | CA2483012C Oligonucleotide compositions and their use for the modulation of immune responses |
| 05/24/2011 | CA2479737C Nanoparticulate compositions of map kinase inhibitors |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2472821C Process for producing fused imidazole compound, and reformatsky reagent in stable form and process for producing the same |
| 05/24/2011 | CA2471642C 6-fluorobicyclo[3.1.0]hexane derivatives |
| 05/24/2011 | CA2468719C Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/24/2011 | CA2467552C Nicotin-or isonicotin benzothiazole derivatives |
| 05/24/2011 | CA2464358C Alkyl ether derivatives or their salts |
| 05/24/2011 | CA2463626C Piperidine- and piperazineacetamines as 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
| 05/24/2011 | CA2450467C Methods for modulating bladder function |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
| 05/24/2011 | CA2439787C Nitrogen-based camptothecin derivatives |
| 05/24/2011 | CA2421562C A method of producing analgesia using sodium channel blocking compounds such as tetrodotoxin, saxitoxin and derivatives thereof |
| 05/24/2011 | CA2415403C Method for obtaining aqueous formulations of oxidation-sensitive active principles |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2397183C Method of treating cellulite using perilla oil |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |